Mar 31, 2023
Featuring perspectives from Dr Sara Tolaney, including the following topics:
• Introduction (00:00)
• Case: A premenopausal woman in her early 30s with T1c N0 ER/PR-positive, HER2-negative, gBRCA2-mutant invasive ductal carcinoma (IDC) with an Oncotype DX® Recurrence Score® (RS) of 30 receives...
Mar 30, 2023
Featuring perspectives from Dr Matthew Galsky, Jonathan Rosenberg, and Dr Arlene Siefker-Radtke, moderated by Dr Elisabeth Heath, including the following topics:
• Integrating Novel Treatment Strategies into the Management of Nonmetastatic Urothelial Bladder Cancer (UBC) — Dr Galsky
o Introduction (00:00)
Mar 23, 2023
Featuring perspectives from Dr Emmanuel Antonarakis, Prof Karim Fizazi, Dr Maha Hussain and Dr Matthew Smith, moderated by Dr Alan Bryce, including the following topics:
• Management Approaches for Nonmetastatic Prostate Cancer — Dr Bryce
o Introduction (00:00)
o Case: A man in his early 70s with...
Mar 22, 2023
Featuring an interview with Drs Gottfried Konecny and Chirag Patel, including the following topics:
• Tumor Treating Fields with Chirag B Patel, MD, PhD
o Introduction (0:00)
o Mechanism of action of tumor treating fields (5:53)
o Tumor treating fields for glioblastoma multiforme (25:08)
o ...
Mar 21, 2023
Featuring perspectives from Dr Richard Finn, Dr Lipika Goyal and Prof Arndt Vogel, moderated by Dr Katie Kelley, including the following topics:
• First-Line Treatment for Advanced Hepatocellular Carcinoma (HCC) — Dr Finn
o Introduction (0:00)
o Case: A man in his early 70s with newly diagnosed...